LifeMD (LFMD) Cash from Operations (2012 - 2025)

LifeMD (LFMD) has reported Cash from Operations for 14 consecutive years, with -$3.3 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations fell 405.65% year-over-year to -$3.3 million; the trailing twelve-month figure through Dec 2025 stood at $8.3 million (down 52.72% YoY), and the FY2025 full-year result was $8.3 million, down 52.72% from the prior year.
• Cash from Operations retreated to -$3.3 million in Q4 2025 per LFMD's latest filing, from -$147136.0 in the prior quarter.
• Across five years, Cash from Operations topped out at $8.6 million in Q2 2025 and bottomed at -$10.7 million in Q2 2021.
• Historically, Cash from Operations has averaged -$1.1 million across 5 years, with a median of -$1.1 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Cash from Operations plunged 1477.0% in 2021, then surged 522.36% in 2024.
• Over 5 years, Cash from Operations stood at -$5.8 million in 2021, then surged by 66.2% to -$2.0 million in 2022, then jumped by 390.17% to $5.7 million in 2023, then slumped by 81.22% to $1.1 million in 2024, then slumped by 405.65% to -$3.3 million in 2025.
• According to Business Quant data, Cash from Operations over the past three periods registered -$3.3 million, -$147136.0, and $8.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.